Related Experiment Video
Updated: Jan 2, 2026
07:53
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
7.6K
Vulvar malignancies: an interdisciplinary perspective.
Christoph Wohlmuth1,2,3, Iris Wohlmuth-Wieser4
1Department of Obstetrics and Gynecology, Paracelsus Medical University, Salzburg, Austria.
Summary
Vulvar cancer, the fourth most common gynecologic malignancy, requires interdisciplinary diagnosis and treatment. Early biopsy mapping and specialized surgical centers improve outcomes for this rare cancer.
Area of Science:
- Gynecologic Oncology
- Dermatology
- Surgical Oncology
Background:
- Vulvar cancer is the fourth most common gynecologic malignancy, often diagnosed late.
- Squamous cell carcinoma (76%) and basal cell carcinoma are common subtypes; vulvar intraepithelial neoplasia is a precursor.
- Vulvar melanoma (5.7%) has a poorer prognosis than cutaneous melanoma.
Purpose of the Study:
- To review the diagnosis and treatment of vulvar cancer.
- To highlight the importance of interdisciplinary care and precise biopsy mapping.
- To discuss current therapeutic options, including surgery, targeted therapy, and checkpoint inhibitors for vulvar melanoma.
Main Methods:
- Review of existing literature on vulvar cancer diagnosis and treatment.
- Analysis of surgical approaches guided by biopsy location and histology.
- Evaluation of preliminary evidence for systemic therapies in vulvar melanoma.
Main Results:
- Accurate biopsy mapping is crucial for surgical planning.
- Surgery is the primary treatment for resectable vulvar cancer.
- Systemic therapies like checkpoint inhibitors show potential for vulvar melanoma.
Conclusions:
- Interdisciplinary management by dermatologists, gynecologists, and oncologists is essential.
- Specialized cancer centers offer optimal disease control and functional preservation.
- Further research into systemic therapies for vulvar melanoma is warranted.
More Related Videos
Related Concept Videos
01:30Skin Cancer
5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
131
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
131
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K